The Problem With Late-Stage Testing

Type 2 diabetes doesn't appear suddenly. It develops over 10–15 years through a progressive process of insulin resistance — a state in which cells become less responsive to insulin's signal, forcing the pancreas to produce more and more to maintain blood sugar control.

Standard metabolic testing — fasting glucose and HbA1c — only become abnormal after this process is well underway. By the time your fasting glucose exceeds 100 mg/dL, insulin resistance has typically been present for years.

Fasting Insulin: The Early Warning Signal

While fasting glucose reflects the current blood sugar level, fasting insulin reflects how hard your pancreas is working to maintain it. A fasting glucose of 90 mg/dL looks perfectly normal. Paired with a fasting insulin of 18 µIU/mL, it tells a very different story — one of compensated insulin resistance that standard testing completely misses.

Functional medicine considers fasting insulin above 8–10 µIU/mL worth addressing, even when glucose is normal. This single marker can identify metabolic risk 5–10 years before standard testing reveals any abnormality.

HOMA-IR: Quantifying Insulin Resistance

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated from fasting glucose and insulin. A score above 1.5 suggests early insulin resistance; above 2.0 is clinically significant. It's a simple calculation from two readily available markers, yet it appears on almost no standard lab order.

Triglyceride-to-HDL Ratio

The ratio of triglycerides to HDL cholesterol is one of the most underutilized markers in standard lipid evaluation. A ratio above 2.0 is strongly associated with insulin resistance and small, dense LDL particles — the atherogenic phenotype that dramatically increases cardiovascular risk. A ratio below 1.0 suggests favorable metabolic function.

This ratio is derivable from a standard lipid panel — no additional testing required — but rarely gets calculated or discussed.

Uric Acid

Uric acid is typically associated with gout. But elevated uric acid is also an independent risk factor for metabolic syndrome, cardiovascular disease, and kidney dysfunction. It rises with fructose consumption, alcohol intake, and cellular turnover — making it a useful metabolic signal well beyond its traditional context.

Connecting the Dots

No single marker tells the full metabolic story. The power is in the pattern — fasting insulin trending up, triglycerides rising, HDL falling, uric acid elevated, waist circumference increasing. Each marker adds signal. Together, they reveal a metabolic trajectory years before it becomes a diagnosis.

This is what comprehensive metabolic assessment looks like. And it's the foundation of everything we do at QIM Health.